We are pleased to share that our new publication, developed in partnership with the IFPA International Federation of Psoriasis Associations, ” Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction”, […]
The first Joint Clinical Assessment report under the EU HTA Regulation is now published. It covers Ojemada® / tovorafenib, for paediatric low-grade glioma.
Across the Nordics, the message from national HTA agencies is consistent:
Do not resubmit clinical evidence already available through […]
Cathrine Tipsmark and Kelsi Smith will be attending EHA 2026 in Stockholm from 11–14 June (Thursday to Sunday).
They will be meeting with leaders across Medical Affairs, Market Access, HEOR, Clinical Development, and Commercial teams to discuss:
📊 Real-world evidence (RWE)
📊 External […]
Last week, colleagues from across Quantify Research gathered for our annual summer party at Södra teatern in Stockholm.
The evening was a chance to celebrate the first half of the year, reflect on what we’ve achieved together, and enjoy time […]
Last week, our colleague Alexandra Wennberg represented Quantify Research at EASL 2026, joining leading researchers, clinicians, and industry experts to discuss the latest advances in liver disease research and patient care.
Several themes […]
Our team in Finland has grown significantly this year, and for that, we owe a huge thank you to our excellent clients and the outstanding work delivered by our consultants.
Our Finnish Modelling, Access & Strategy team combines extensive experience from […]
Alexandra Wennberg is on her way to Barcelona for the EASL 2026 Congress ✈️
Over the coming days, she will meet clients and colleagues to discuss real-world evidence in liver disease and share perspectives from the Quantify Research Liver Disease Platform.
Nordic […]
Oskar Ström and Johan Liseth Hansen will be attending the ASCO 2026 Annual Meeting in Chicago from 29 May to 2 June.
They will be meeting partners and discussing the Quantify Research Nordic Oncology RWD Platform — a study-ready data asset […]
After several days of insightful discussions, reconnecting with colleagues, and exchanging perspectives on the future of HEOR and RWE, we are now heading home from ISPOR 2026.
It has been a highly productive […]